Status:
RECRUITING
Peanut Consumption on Cognitive, Weight, and Inflammation
Lead Sponsor:
University of Barcelona
Collaborating Sponsors:
Gasol Foundation
Universitat Oberta de Catalunya
Conditions:
Cognitive Performance
Inflammation
Eligibility:
All Genders
10-12 years
Phase:
NA
Brief Summary
A multi-school, two-arm parallel cluster-randomized controlled trial will be conducted in 200 healthy young adolescents from Barcelona (Spain) to evaluate the effect of peanut consumption on cognitive...
Detailed Description
Background: Regular nut consumption has been associated with reduced inflammation, oxidative damage, and improved vascular function, which may benefit cognitive function. Their content in phenolic ac...
Eligibility Criteria
Inclusion
- Eligible participants will be young adolescents, boys and girls, aged between 10 and 12 years who attend regular primary schools in Barcelona. The schools will assist with the participant recruitment through the classes and after that, a total of one-hundred students will be randomly included in each group. In all cases, participation will be voluntary and informed consent will be obtained prior to the study.
Exclusion
- The exclusion criteria will be history of allergy or intolerance to peanuts, any medical conditions or dietary restrictions that would affect peanut consumption, being able to understand Spanish or Catalan, and use of antibiotics in the month prior to the study.
Key Trial Info
Start Date :
January 29 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06127511
Start Date
January 29 2024
End Date
December 31 2025
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IDIBAPS
Barcelona, Barcelona, Spain, 08036